We are improving our search experience. To check which content you have full access to, or for advanced search, go back to the old search.

Search

Please fill in this field.
Filters applied:

Search Results

Showing 1-20 of 10,000 results
  1. Engineering Homogeneous Photoactive Antibody Fragments

    Genetically encoded site-specifically incorporated noncanonical amino acids (ncAAs) have been used to modulate properties of several proteins. Here,...
    Thomas Bridge, Amit Sachdeva in Genetically Incorporated Non-Canonical Amino Acids
    Protocol 2023
  2. Homogeneous multi-payload antibody–drug conjugates

    Many systemic cancer chemotherapies comprise a combination of drugs, yet all clinically used antibody–drug conjugates (ADCs) contain a single-drug...

    Toby Journeaux, Gonçalo J. L. Bernardes in Nature Chemistry
    Article 17 May 2024
  3. Design and Construction of Antibody Fusion Proteins Incorporating Variable New Antigen Receptor (VNAR) Domains

    Antibody therapeutics have become a cornerstone of the pharmaceutical market due to their precise molecular targeting, favorable pharmacokinetic...
    Seth D. Ludwig, Angela Zhu, ... Jamie B. Spangler in Therapeutic Proteins
    Protocol 2024
  4. Antibody–peptide conjugates deliver covalent inhibitors blocking oncogenic cathepsins

    Cysteine cathepsins are a family of proteases that are relevant therapeutic targets for the treatment of different cancers and other diseases....

    Aaron Petruzzella, Marine Bruand, ... Elisa Oricchio in Nature Chemical Biology
    Article 29 May 2024
  5. Understanding the Specific Implications of Amino Acids in the Antibody Development

    As the demand for immunotherapy to treat and manage cancers, infectious diseases and other disorders grows, a comprehensive understanding of amino...

    Akshata Gavade, Anil Kumar Nagraj, ... Jaspal Patil in The Protein Journal
    Article 09 May 2024
  6. Druggability properties of a L309K mutation in the antibody CH2 domain

    In the early stages of antibody drug development, it is imperative to conduct a comprehensive assessment and enhancement of the druggability...

    Cui Li, Qing-qing Yao, Jiang Li in 3 Biotech
    Article 11 May 2024
  7. Development and Characterization of Guinea Pig Anti-Insulin Polyclonal Antibody

    Development and characterization of guinea pig anti-insulin polyclonal antibody against a target-specific insulin antigen. In India, an insulin...

    Sathiya Varadarajan, Arumugam Muruganandam, V. Ramesh Kumar in Applied Biochemistry and Biotechnology
    Article 15 September 2023
  8. Ligand-Directed GPCR Antibody Discovery

    Develo** affinity reagents recognizing and modulating G-protein coupled receptors (GPCR) function by traditional animal immunization or in vitro...
    Qi Zhao, Amanda Chapman, ... **aofeng Li in Biomedical Engineering Technologies
    Protocol 2022
  9. Antibody discovery identifies regulatory mechanisms of protein arginine deiminase 4

    Unlocking the potential of protein arginine deiminase 4 (PAD4) as a drug target for rheumatoid arthritis requires a deeper understanding of its...

    **n Zhou, Sophie Kong, ... James A. Wells in Nature Chemical Biology
    Article Open access 02 February 2024
  10. Probing Antibody Structures by Hydrogen/Deuterium Exchange Mass Spectrometry

    Hydrogen/deuterium exchange (HDX) followed by mass spectrometry detection (MS) provides a fast, reliable, and detailed solution for the assessment of...
    Zuzana Kalaninová, Lukáš Fojtík, ... Petr Man in Mass Spectrometry-Based Proteomics
    Protocol 2023
  11. Application of Computational Techniques in Antibody Fc-Fused Molecule Design for Therapeutics

    Since the advent of hybridoma technology in the year 1975, it took a decade to witness the first approved monoclonal antibody Orthoclone OKT39...

    Chong Lee Ng, Theam Soon Lim, Yee Siew Choong in Molecular Biotechnology
    Article 24 September 2023
  12. Antibody Purification Using Affinity Chromatography

    Antibodies are an integral part of many biological assays and biotherapeutics. However, the sources from which antibodies are derived frequently...
    Arabelle Cassedy, Richard O’Kennedy in Affinity Chromatography
    Protocol 2022
  13. Application of the CRISPR/Cas9 Gene Editing Method for Modulating Antibody Fucosylation in CHO Cells

    Genetic engineering plays an essential role in the development of cell lines for biopharmaceutical manufacturing. Advanced gene editing tools can...
    Qiong Wang, Lateef Aliyu, ... Michael J. Betenbaugh in Recombinant Protein Expression in Mammalian Cells
    Protocol 2024
  14. Enhancing antibody affinity through experimental sampling of non-deleterious CDR mutations predicted by machine learning

    The application of machine learning (ML) models to optimize antibody affinity to an antigen is gaining prominence. Unfortunately, the small and...

    Thomas Clark, Vidya Subramanian, ... Ram Sasisekharan in Communications Chemistry
    Article Open access 09 November 2023
  15. Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments

    Rheumatoid arthritis (RA) is a systemic immune disease characterized by synovial inflammation. Patients with RA commonly experience significant...

    **ao-Kai Chi, **ao-Ling Xu, ... Yong-Zhong Du in Journal of Nanobiotechnology
    Article Open access 25 March 2023
  16. Method for Measurement of Antibody-Dependent Cellular Phagocytosis

    Antibody-based therapeutics are powerful tools to treat disease. While their mechanism of action (MOA) always involves binding to a specific target...
    Lynn Kamen, Benjamin Ordonia, ... Shan Chung in Therapeutic Antibodies
    Protocol 2022
  17. Measuring Antibody-Mediated Tau Fibril Uptake in Microglia by Flow Cytometry

    Microglia are brain-resident phagocytic cells, considered to be the innate immune cells of the central nervous system. Microglia respond to both...
    Kristen E. Funk in Tau Protein
    Protocol 2024
  18. Application of a Novel Aptamer Beacon for Rapid Detection of IgG1 Antibody Drugs

    Antibody drugs have been widely used to treat many diseases and are the fastest-growing drug class. IgG1 is the most common type of antibody because...

    Ke Yang, Wei-Wei Zheng, ... Cai-Wen Duan in Applied Biochemistry and Biotechnology
    Article 28 March 2023
  19. Study of antibody repertoire to oligosaccharide fragments of polyglucosamines and galactosaminoglycans in sera from healthy human donors

    Naturally circulating antibodies could dramatically change the activity of immunogens. In some cases, cross-interference between antibodies led to...

    M. L. Gening, A. V. Polyanskaya, ... N. E. Nifantiev in Russian Chemical Bulletin
    Article 01 May 2024
  20. The Therapeutic Antibody Profiler for Computational Developability Assessment

    The need to consider an antibody’s “developability” (immunogenicity, solubility, specificity, stability, manufacturability, and storability) is now...
    Matthew I. J. Raybould, Charlotte M. Deane in Therapeutic Antibodies
    Protocol 2022
Did you find what you were looking for? Share feedback.